2008
DOI: 10.1016/j.colsurfb.2007.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Photothermal ablation of amyloid aggregates by gold nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
49
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(51 citation statements)
references
References 33 publications
1
49
0
Order By: Relevance
“…Therefore, the cysteine used to coat the AuNPs must be capable of binding hydrophobic moieties of misfolding proteins, thereby preventing their aggregation and thus creating an environment for their refolding. It was observed previously that AuNPs are capable of reversing protein aggregation when combined with light energy (19). Based on the previous study and our current study, it appears that AuNPs may possess the capability to suppress aggregation of proteins, and may thus possibly facilitate their refolding.…”
Section: Figsupporting
confidence: 75%
See 1 more Smart Citation
“…Therefore, the cysteine used to coat the AuNPs must be capable of binding hydrophobic moieties of misfolding proteins, thereby preventing their aggregation and thus creating an environment for their refolding. It was observed previously that AuNPs are capable of reversing protein aggregation when combined with light energy (19). Based on the previous study and our current study, it appears that AuNPs may possess the capability to suppress aggregation of proteins, and may thus possibly facilitate their refolding.…”
Section: Figsupporting
confidence: 75%
“…Furthermore, the prospects of AuNPs serving as some form of artificial chaperone systems have broad implications in the biomedical and protein biotechnology sectors. For example, AuNPs have been proposed as potential therapies as exposure of protein aggregates to these nanoparticles with accompanying application of photothermal treatment led to the disaggregation of the protein complexes suggesting that AuNPs could be used to treat conditions such as Alzheimer's disease (19). In a previous study, it was observed that AuNPs improved the efficiency of amplifying DNA by the polymerase chain reaction (23).…”
Section: Figmentioning
confidence: 99%
“…Various drug nano-carriers have been successfully synthesized to transport small molecules, especially hydrophilic ones, across the BBB. [13][14][15][16][17] So, if NPs can inhibit the process of fibrillogenesis or disaggregate amyloid fibrils, 18 they offer great potential to be used as drugs to control neurodegenerative amyloid disease. On the other hand, detailed information about the interactions between NPs and amyloid proteins could shed light on the mechanism of fibril formation at the molecular level, an area which…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, feasibility in conjugating various drugs, peptides, proteins, antibodies, etc., made them suitable nanoparticulate drug delivery system in the field of oncology. Furthermore, apart from their control over the size, ease in preparation, the presence of carboxyl and amine groups help them in surface modification that could be efficiently targeted to attain site specificity (Gibson et al, 2007;Kattumuri et al, 2007;Triulzi et al, 2008;Fent et al, 2009;Lu et al, 2009). Active targeting drug delivery is the method for transporting chemotherapeutic agents to the diseased cells (Peer et al, 2007;Kamaly et al, 2012;Zhang et al, 2012).…”
Section: Introductionmentioning
confidence: 99%